GME.DE - Geratherm Medical AG

XETRA - XETRA Delayed Price. Currency in EUR

Geratherm Medical AG

Fahrenheitstrasse 1
Geschwenda 98716
49 36205 980

IndustryMedical Appliances & Equipment
Full Time Employees207

Key Executives

Dr. Gert Michael Frank Dipl.Chairman of Management Board and Chief Exec. OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Geratherm Medical AG operates as a medical technology company primarily in Germany. The company operates through Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke, and Respiratory segments. The Healthcare Diagnostic segment offers clinical thermometers; blood pressure monitors; and self-test diagnostic products for women, including pregnancy tests, ovulation test solutions, chlamydia tests, yeast infection test kits, and pH tests. The Medical Warming Systems segment provides warming systems under the UniqueTemp and Unique Resc+ brand names to maintain body temperature during operations and in rescue situations; and nomag IC, an incubator system for premature and newborn infants under the LMT brand. The Cardio/Stroke segment offers Stroke-Risk-Analyser brand products, including SRAclinic for identifying atrial fibrillation for stroke prevention. The Respiratory segment develops and manufactures Spirostik, Spirostik Complete, and spiroergometer primarily for pulmonary and cardiopulmonary function diagnostics. The company markets its products through pharmacies, hospitals, and clinics. Geratherm Medical AG exports its products to Europe, Germany, South America, the Middle East, the United States, and internationally. The company is headquartered in Geschwenda, Germany. Geratherm Medical AG is a subsidiary of GMF Beteiligungsberatung GmbH, Frankfurt am Main.

Corporate Governance

Geratherm Medical AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.